Coeptis Therapeutics, Inc. (COEP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 12.77 |
| Open | 12.52 |
| Day High | 15.15 |
| Day Low | 12.52 |
| 52-Week High | 21.41 |
| 52-Week Low | 6.8 |
| Volume | 5,334 |
| Average Volume | 50,880 |
| Market Cap | 52.11M |
| PE | -5.28 |
| EPS | -2.81 |
| Moving Average 50 Days | 12.25 |
| Moving Average 200 Days | 13.72 |
| Change | 2.06 |
Data not available
Coeptis Receives Shareholder Approval Towards Z Squared Merger
GlobeNewswire Inc.
Feb 05, 2026 9:00 PM GMT
Shareholder Approval Clears a Key Condition to CloseWEXFORD, Pa., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, today announce
Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared
GlobeNewswire Inc.
Jan 06, 2026 1:19 PM GMT
~ Annual/Special Meeting of Shareholders to be Held on January 30, 2026 ~WEXFORD, Pa., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical co
Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating
GlobeNewswire Inc.
Sep 23, 2025 12:00 PM GMT
COEP Balances Revenue Generation With Breakthrough Cell Therapy DevelopmentBRISTOL, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- VanderbiltReport.com, a financial news and content platform, reports that Coeptis Therapeutics (NASDAQ: COEP) is pioneerin